BMO Capital Reiterates Outperform Rating on ACADIA Pharmaceuticals Inc. (ACAD)
Rating Change BMO Capital analysts reiterated a Outperform rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on July 21, 2026. Market Context ACADIA Pharmaceuticals Inc.
Read more
